GlySure
Continuous intravascular glucose monitoring system for tight glycemic control (TGC) in the hospital
Total raised
€21M
€20,763,636
Funding rounds
2
Investors
2
distinct backers
Active since
2011-12
latest 2012-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood23
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 20y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-11-01 | Series C | €12M | Amadeus Capital Partners,Delta Partners | View deal → |
| 2012-01-01 | Series C | €8.4M | Amadeus Capital Partners,Delta Partners | View deal → |